Research ArticleBehavioral Pharmacology
Fatty acid amide hydrolase (FAAH) inhibition reduces L-DOPA-induced hyperactivity in the MPTP-lesioned non-human primate model of Parkinson's disease
Tom H Johnston, Philippe Huot, Susan H Fox, James D Wakefield, Kristine A Sykes, Wilmin P Bartolini, G Todd Milne, James P Pearson and Jonathan M Brotchie
Journal of Pharmacology and Experimental Therapeutics October 21, 2010, jpet.110.169532; DOI: https://doi.org/10.1124/jpet.110.169532
Tom H Johnston
Philippe Huot
Susan H Fox
James D Wakefield
Kristine A Sykes
Wilmin P Bartolini
G Todd Milne
James P Pearson
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleBehavioral Pharmacology
Fatty acid amide hydrolase (FAAH) inhibition reduces L-DOPA-induced hyperactivity in the MPTP-lesioned non-human primate model of Parkinson's disease
Tom H Johnston, Philippe Huot, Susan H Fox, James D Wakefield, Kristine A Sykes, Wilmin P Bartolini, G Todd Milne, James P Pearson and Jonathan M Brotchie
Journal of Pharmacology and Experimental Therapeutics October 21, 2010, jpet.110.169532; DOI: https://doi.org/10.1124/jpet.110.169532
Research ArticleBehavioral Pharmacology
Fatty acid amide hydrolase (FAAH) inhibition reduces L-DOPA-induced hyperactivity in the MPTP-lesioned non-human primate model of Parkinson's disease
Tom H Johnston, Philippe Huot, Susan H Fox, James D Wakefield, Kristine A Sykes, Wilmin P Bartolini, G Todd Milne, James P Pearson and Jonathan M Brotchie
Journal of Pharmacology and Experimental Therapeutics October 21, 2010, jpet.110.169532; DOI: https://doi.org/10.1124/jpet.110.169532
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement